tiprankstipranks
Trending News
More News >
Rallybio (RLYB)
NASDAQ:RLYB
US Market
Advertisement

Rallybio (RLYB) Stock Statistics & Valuation Metrics

Compare
348 Followers

Total Valuation

Rallybio has a market cap or net worth of $23.78M. The enterprise value is -$30.53M.
Market Cap$23.78M
Enterprise Value-$30.53M

Share Statistics

Rallybio has 41,786,472 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding41,786,472
Owned by Insiders14.39%
Owned by Institutions58.76%

Financial Efficiency

Rallybio’s return on equity (ROE) is -0.94 and return on invested capital (ROIC) is -93.53%.
Return on Equity (ROE)-0.94
Return on Assets (ROA)-0.85
Return on Invested Capital (ROIC)-93.53%
Return on Capital Employed (ROCE)-0.98
Revenue Per Employee25.44K
Profits Per Employee-2.31M
Employee Count25
Asset Turnover<0.01
Inventory Turnover0.00

Valuation Ratios

The current PE Ratio of Rallybio is ―. Rallybio’s PEG ratio is ―.
PE Ratio
PS Ratio
PB Ratio
Price to Fair Value0.68
Price to FCF
Price to Operating Cash Flow-0.63
PEG Ratio

Income Statement

In the last 12 months, Rallybio had revenue of 636.00K and earned -57.77M in profits. Earnings per share was -1.33.
Revenue636.00K
Gross Profit636.00K
Operating Income-60.50M
Pretax Income-57.77M
Net Income-57.77M
EBITDA-60.50M
Earnings Per Share (EPS)-1.33

Cash Flow

In the last 12 months, operating cash flow was -41.99M and capital expenditures 0.00, giving a free cash flow of -41.99M billion.
Operating Cash Flow-41.99M
Free Cash Flow-41.99M
Free Cash Flow per Share-1.00

Dividends & Yields

Rallybio pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share
Dividend Yield
Payout RatioN/A
Free Cash Flow Yield
Earnings Yield

Stock Price Statistics

Beta0.91
52-Week Price Change-46.36%
50-Day Moving Average0.45
200-Day Moving Average0.64
Relative Strength Index (RSI)60.09
Average Volume (3m)653.98K

Important Dates

Rallybio upcoming earnings date is Nov 6, 2025, Before Open (Confirmed).
Last Earnings DateAug 7, 2025
Next Earnings DateNov 6, 2025
Ex-Dividend Date

Financial Position

Rallybio as a current ratio of 10.87, with Debt / Equity ratio of 0.13%
Current Ratio10.87
Quick Ratio10.87
Debt to Market Cap<0.01
Net Debt to EBITDA0.23
Interest Coverage Ratio0.00

Taxes

In the past 12 months, Rallybio has paid -2.24M in taxes.
Income Tax-2.24M
Effective Tax Rate0.04

Enterprise Valuation

Rallybio EV to EBITDA ratio is -0.46, with an EV/FCF ratio of -0.57.
EV to Sales44.11
EV to EBITDA-0.46
EV to Free Cash Flow-0.57
EV to Operating Cash Flow-0.57

Balance Sheet

Rallybio has $45.75M in cash and marketable securities with $58.00K in debt, giving a net cash position of -$45.69M billion.
Cash & Marketable Securities$45.75M
Total Debt$58.00K
Net Cash-$45.69M
Net Cash Per Share-$1.09
Tangible Book Value Per Share$1.42

Margins

Gross margin is 96.06%, with operating margin of -9511.95%, and net profit margin of -9084.12%.
Gross Margin96.06%
Operating Margin-9511.95%
Pretax Margin-9084.12%
Net Profit Margin-9084.12%
EBITDA Margin-9511.95%
EBIT Margin-9511.95%

Analyst Forecast

The average price target for Rallybio is $1.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$1.00
Price Target Upside69.49% Upside
Analyst ConsensusModerate Buy
Analyst Count2
Revenue Growth Forecast154.52%
EPS Growth Forecast47.84%

Scores

Smart Score6
AI Score35
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis